article thumbnail

Top 7 Pharma Industry Leaders in 2020 By the Numbers

Delveinsight

MAVYRET (Glecaprevir and pibrentasvir) (for Chronic HCV genotype), Skyrizi (Risankizumab) (for plaque psoriasis), and VENCLEXTA (Venetoclax) (for Chronic lymphocytic leukemia, and Acute Myeloid Leukemia) generated nearly same amount of revenue share i.e. 0.3% (USD 1.8 Imbruvica contributed USD 5.3 billion , around 11.5% of revenue share.